I-Mab (NASDAQ: IMAB) Analysis: Is It The One You’re Looking For?

view original post

I-Mab (NASDAQ:IMAB) traded at $11.90 at close of the session on Tuesday, 04/26/22, made a downward move of -6.00% on its previous day’s price.

Looking at the stock we see that its previous close was $12.66 with the day’s price range being $11.70 – $12.66. In terms of its 52-week price range, IMAB has a high of $85.40 and a low of $12.00. The company’s stock has lost about -33.11% over that past 30 days.

I-Mab has a market cap of $1.07 billion and is expected to release its quarterly earnings report on Aug 31, 2021.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the IMAB stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Based on estimates by 13 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the I-Mab (IMAB) stock as a Hold, while 13 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is -22.43% off its SMA20 and -37.86% from its 50-day simple moving average. The RSI (14) is pointing at 35.78 while the volatility over the past week is 9.80% and jumps to 10.40% over the past one month. The average price target for the stock over the next 12 months is $78.09, with the estimates having a low of $45.00 and a high of $103.60. These price ends are -278.15% and -770.59% off the current price level respectively, although investors could be excited at the prospect of a -572.27% if the IMAB share price touches on the median price of $80.00.

Let’s briefly compare I-Mab (IMAB) stock to its peers. We find that current price change of -6.00% and -81.53% over the past 12 months for IMAB competes that of Johnson & Johnson (JNJ), which has seen its stock price fall -0.72% in the last trading session and was 13.18% over the last one year. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at -2.81% and -2.38%, respectively, at close of the trading.

Coming back to I-Mab (NASDAQ:IMAB), we note that the average 3-month trading volume was 1.29 million, while that of the preceding 10-day period stands at 2.37 million. Current shares outstanding are 78.52 million.

The insiders hold 1.15% of the company’s shares while institutions hold 57.30%. The data shows that short shares as of Dec 14, 2021, stood at 2.62 million at a short ratio of 4.98. This represents a 3.36% short interest in shares outstanding on Dec 14, 2021. Shares short fall in December from the previous month at 2.68 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -74.89% down in year-to-date price movement.